Our broad portfolio consists of multiplex panels that allow you to choose, within the panel, analytes that best meet your needs. On a separate tab you can choose the premixed cytokine format or a single plex kit.
Cell Signaling Kits & MAPmates™
Choose fixed kits that allow you to explore entire pathways or processes. Or design your own kits by choosing single plex MAPmates™, following the provided guidelines.
The following MAPmates™ should not be plexed together:
-MAPmates™ that require a different assay buffer
-Phospho-specific and total MAPmate™ pairs, e.g. total GSK3β and GSK3β (Ser 9)
-PanTyr and site-specific MAPmates™, e.g. Phospho-EGF Receptor and phospho-STAT1 (Tyr701)
-More than 1 phospho-MAPmate™ for a single target (Akt, STAT3)
-GAPDH and β-Tubulin cannot be plexed with kits or MAPmates™ containing panTyr
.
Catalogue Number
Ordering Description
Qty/Pack
List
This item has been added to favorites.
Select A Species, Panel Type, Kit or Sample Type
To begin designing your MILLIPLEX® MAP kit select a species, a panel type or kit of interest.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
This item has been added to favorites.
Species
Panel Type
Selected Kit
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
96-Well Plate
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
Add Additional Reagents (Buffer and Detection Kit is required for use with MAPmates)
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Space Saver Option Customers purchasing multiple kits may choose to save storage space by eliminating the kit packaging and receiving their multiplex assay components in plastic bags for more compact storage.
This item has been added to favorites.
The Product Has Been Added To Your Cart
You can now customize another kit, choose a premixed kit, check out or close the ordering tool.
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More
567430
Sigma-AldrichSodium Butyrate - CAS 156-54-7 - Calbiochem
Sodium Butyrate, CAS 156-54-7, is a short chain fatty acid that induces apoptosis in colon carcinoma cells by a p53-independent pathway. Down-regulates the activity of casein kinase II in HT29 cells.
More>>Sodium Butyrate, CAS 156-54-7, is a short chain fatty acid that induces apoptosis in colon carcinoma cells by a p53-independent pathway. Down-regulates the activity of casein kinase II in HT29 cells. Less<<
Sodium Butyrate - CAS 156-54-7 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
A short chain fatty acid that has been shown to induce apoptosis in colon carcinoma cell lines by a p53-independent pathway. Inhibits c-myc splicing and interferes with signal transduction processes, including the release of Ca2+ from intracellular stores. Reduces histamine-induced calcium mobilization in C6 glioma cells. Down-regulates the activity of the serine/threonine protein kinase casein kinase II in HT29 cells.
Catalogue Number
567430
Brand Family
Calbiochem®
Synonyms
Butyric Acid, Na, NaB, HDAC Inhibitor V
References
References
Ou, H.C., et al. 1997. Neuroreport 8, 1375. Russo, G.L., et al. 1997. Biochem. Biophys. Res. Commun. 233, 673. Krupitza, G., et al. 1995. Carcinogenesis16, 1199. Calabresse, C., et al. 1993. Biochem. Biophys. Res. Commun.195, 31. Hague, A., et al. 1993. Int. J. Cancer55, 498.
Sodium Butyrate, CAS 156-54-7, is a short chain fatty acid that induces apoptosis in colon carcinoma cells by a p53-independent pathway. Down-regulates the activity of casein kinase II in HT29 cells.
Biological Information
Primary Target
Induce apoptosis
Purity
≥98% by titration
Physicochemical Information
Cell permeable
N
Safety Information according to GHS
RTECS
ET6400000
Safety Information
R Phrase
R: 20/21/22-36/37/38
Harmful by inhalation, in contact with skin and if swallowed. Irritating to eyes, respiratory system and skin.
S Phrase
S: 26-36
In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing.
Storage and Shipping Information
Ship Code
Ambient Temperature Only
Toxicity
Irritant
Storage
-20°C
Hygroscopic
Hygroscopic
Do not freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Sodium Butyrate - CAS 156-54-7 - Calbiochem Certificates of Analysis
Title
Lot Number
567430
References
Reference overview
Ou, H.C., et al. 1997. Neuroreport 8, 1375. Russo, G.L., et al. 1997. Biochem. Biophys. Res. Commun. 233, 673. Krupitza, G., et al. 1995. Carcinogenesis16, 1199. Calabresse, C., et al. 1993. Biochem. Biophys. Res. Commun.195, 31. Hague, A., et al. 1993. Int. J. Cancer55, 498.
Data Sheet
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
Revision
11-September-2008 RFH
Synonyms
Butyric Acid, Na, NaB, HDAC Inhibitor V
Description
A short chain fatty acid that has been shown to induce apoptosis in colon carcinoma cell lines in a p53-independent pathway. Inhibits c-myc splicing and interferes with signal transduction processes, including the release of Ca2+ from intracellular stores. Downregulates the activity of serine/threonine protein kinase casein kinase II in HT29 cells.
Form
White solid
CAS number
156-54-7
RTECS
ET6400000
Chemical formula
C₄H₇O₂Na
Structure formula
Purity
≥98% by titration
Solubility
H₂O (2 mg/ml)
Storage
-20°C
Hygroscopic
Do Not Freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity
Irritant
References
Ou, H.C., et al. 1997. Neuroreport 8, 1375. Russo, G.L., et al. 1997. Biochem. Biophys. Res. Commun. 233, 673. Krupitza, G., et al. 1995. Carcinogenesis16, 1199. Calabresse, C., et al. 1993. Biochem. Biophys. Res. Commun.195, 31. Hague, A., et al. 1993. Int. J. Cancer55, 498.